Sex differences in the efficacy, safety and persistence of patients with psoriatic arthritis treated with tofacitinib: a post-hoc analysis of phase 3 trials and long-term extension.

RMD open(2023)

引用 2|浏览27
暂无评分
摘要
NCT01877668; NCT01882439; NCT01976364.
更多
查看译文
关键词
arthritis, psoriatic,outcome assessment, health care,therapeutics
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要